BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19221279)

  • 1. Oral contraceptive and D-dimer level.
    Kittisupamongkol W
    Arch Dermatol; 2009 Feb; 145(2):210; author reply 210-1. PubMed ID: 19221279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemocoagulation disorders in patients with acute pancreatitis].
    Dronov OI; Koval's'ka IO; Burmich KS; Tsymbaliuk RS; Uvarov VIu; Lubenets' TV
    Lik Sprava; 2010; (7-8):38-44. PubMed ID: 21714285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of D-dimer testing in patients with venous malformations.
    Maguiness S; Koerper M; Frieden I
    Arch Dermatol; 2009 Nov; 145(11):1321-4. PubMed ID: 19917966
    [No Abstract]   [Full Text] [Related]  

  • 4. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
    Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
    Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.
    Abdollahi M; Cushman M; Rosendaal FR
    Thromb Haemost; 2003 Mar; 89(3):493-8. PubMed ID: 12624633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraglomerular coagulation in patients with glomerulonephritis, with special reference to FDP D-dimer].
    Shibata T; Ura S; Hirai Y; Taura K; Harada T; Hara K
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1143-9. PubMed ID: 6663183
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
    Trofatter KF; Howell ML; Greenberg CS; Hage ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any effect of tumor burden on hemostatic parameters in cancer patients? A case-control study of hemostatic abnormalities and anticardiolipin antibodies in solid tumors.
    Turna H; Ozguroglu M; Bolayirli M; Orhanoglu T; Balci H
    Clin Appl Thromb Hemost; 2009; 15(4):454-7. PubMed ID: 18160567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
    Kluft C; Meijer P; LaGuardia KD; Fisher AC
    Contraception; 2008 Feb; 77(2):77-83. PubMed ID: 18226669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does D-dimer help when blood coagulates?].
    Lassila R
    Duodecim; 1999; 115(24):2707-9. PubMed ID: 11979609
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
    Saito T; Yamamoto Y; Matsumura T; Nozaki S; Fujimura H; Shinno S
    Brain Dev; 2005 Sep; 27(6):415-8. PubMed ID: 16122628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.
    Haas FJ; Schutgens RE; Biesma DH; Laterveer RH; Kluft C
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):297-304. PubMed ID: 23187785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer: standardization versus harmonization.
    Dempfle CE
    Thromb Haemost; 2006 Mar; 95(3):399-400. PubMed ID: 16525565
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative values of molecular coagulation markers identify patients at low risk for intraoperative haemostatic disorders and excessive blood loss.
    Korte W; Truttmann B; Heim C; Stangl U; Schmid L; Kreienbühl G
    Clin Chem Lab Med; 1998 Apr; 36(4):235-40. PubMed ID: 9638349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostasis and intracranial surgery.
    van der Sande JJ; Veltkamp JJ; Bouwhuis-Hoogerwerf ML
    J Neurosurg; 1983 May; 58(5):693-8. PubMed ID: 6834118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 20. Markers of coagulation activation in inherited protein S deficiency.
    Leroy-Matheron C; Lamare M; Levent M; Gouault-Heilmann M
    Thromb Res; 1992 Sep; 67(5):607-12. PubMed ID: 1448792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.